Curis anticipates TakeAim CLL initial 5-patient dosing by mid-2026 while projecting cash runway into second half of '27
Curis Inc · Now $0.52
-4.0% in 3d after detection
Post-detection moves
1h
—
1d
+2.7%
3d
-4.0%
7d
+0.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS